Document is current
Any future updates will be listed below
-
Authors
Li, Sisi
Xi, Quansheng
Zhang, Xiaoyu
Yu, Dong
Li, Lin
Jiang, Zhenyang
Chen, Qiuyun
Wang, Qing K.
Traboulsi, Elias I.
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (91439129, 31430047)
National Heart, Lung, and Blood Institute (R01 HL121358 and R01 HL126729)
Hubei Province Natural Science Key Program (2014CFA074)
Chinese National Basic Research Programs (973 Programs 2013CB531101 and 2012CB517801)
Hubei Province’s Outstanding Medical Academic Leader Program
Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education
“Innovative Development of New Drugs” Key Scientific Project (2011ZX09307-001-09)
unrestricted grant from Research to Prevent Blindness
The Bureau of Human Resources and Social Security of Wuhan City (2016 Top-Notch Innovative Talent Development Project)
- License Information
-
More Information
Article History
Received: 6 February 2017
Accepted: 6 January 2018
First Online: 10 January 2018
Compliance with ethical standards
: This study was approved by appropriate local institutional review boards on human subject research and conformed to the guidelines set forth by the Declaration of Helsinki.
: All authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the IRB on human subject research at Cleveland Clinic and the Ethics Committee on human subject research at Huazhong University of Science and Technology and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all the study subjects.
